Suntrust Banks’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$4.35M Sell
18,126
-2,877
-14% -$788K 0.02% 371
2019
Q2
$5.93M Sell
21,003
-2,208
-10% -$603K 0.03% 322
2019
Q1
$6.66M Buy
23,211
+1,536
+7% +$444K 0.04% 291
2018
Q4
$5.69M Buy
21,675
+3,739
+21% +$1.03M 0.03% 292
2018
Q3
$4.92M Buy
17,936
+210
+1% +$54.5K 0.03% 326
2018
Q2
$4.22M Sell
17,726
-3,002
-14% -$695K 0.02% 356
2018
Q1
$4.55M Buy
20,728
+5,879
+40% +$1.38M 0.03% 324
2017
Q4
$3.34M Sell
14,849
-11,117
-43% -$2.37M 0.02% 360
2017
Q3
$4.93M Buy
25,966
+1,831
+8% +$348K 0.03% 306
2017
Q2
$4.54M Buy
24,135
+11,111
+85% +$2M 0.03% 310
2017
Q1
$2.15M Sell
13,024
-17,226
-57% -$2.74M 0.01% 451
2016
Q4
$4.35M Sell
30,250
-12,115
-29% -$1.62M 0.03% 322
2016
Q3
$5.31M Buy
42,365
+4,737
+13% +$612K 0.03% 279
2016
Q2
$4.94M Sell
37,628
-3,409
-8% -$466K 0.03% 285
2016
Q1
$5.7M Buy
41,037
+3,256
+9% +$435K 0.04% 249
2015
Q4
$5.27M Buy
37,781
+20,018
+113% +$2.76M 0.03% 255
2015
Q3
$2.49M Buy
17,763
+15
+0.1% +$2.25K 0.02% 371
2015
Q2
$2.91M Sell
17,748
-2,996
-14% -$479K 0.02% 350
2015
Q1
$3.2M Buy
20,744
+9,686
+88% +$1.38M 0.02% 320
2014
Q4
$1.39M Sell
11,058
-5,733
-34% -$708K 0.01% 502
2014
Q3
$2.01M Buy
16,791
+2,661
+19% +$305K 0.01% 429
2014
Q2
$1.52M Sell
14,130
-1,039,810
-99% -$107M 0.01% 530
2014
Q1
$105M Buy
1,053,940
+1,020,455
+3,047% +$92.3M 0.39% 56
2013
Q4
$3.09M Buy
33,485
+423
+1% +$37.6K 0.01% 550
2013
Q3
$2.76M Sell
33,062
-1,751
-5% -$150K 0.01% 576
2013
Q2
$2.85M Buy
+34,813
New +$2.61M 0.01% 529

Other funds holding ELV

Suntrust Banks's ELV Position: Q3 2019 in Review

Suntrust Banks reduced its Elevance Health (ELV) stake by 14% in Q3 2019, selling an estimated $788K and leaving 18,126 shares worth $4.35M. The position accounts for 0.02% of the portfolio, ranked #371.

Suntrust Banks first reported a position in ELV in Q2 2013 and has held it in 26 quarters since. The position peaked at $105M in Q1 2014. 1,015 funds tracked by Wall St. Rank hold ELV as of Q3 2019.

  • Suntrust Banks held 18,126 shares of Elevance Health worth $4.35M as of Q3 2019.
  • Suntrust Banks sold 2,877 Elevance Health shares in Q3 2019, an estimated $788K.
  • Elevance Health made up 0.02% of Suntrust Banks's portfolio in Q3 2019, its #371 holding.
  • Suntrust Banks first reported a position in Elevance Health in Q2 2013 and has held it in 26 quarters since.
  • Suntrust Banks's Elevance Health position peaked at $105M in Q1 2014.
  • 1,015 funds tracked by Wall St. Rank held Elevance Health as of Q3 2019.

Based on Suntrust Banks's 13F filing for Q3 2019, filed 12 Nov 2019.